Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT00602329
Title MRI in Predicting Response in Patients Receiving Combination Chemotherapy and Bevacizumab For Advanced or Metastatic Colorectal Cancer
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of Pennsylvania
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Abramson Cancer Center of the University of Pennsylvania Philadelphia Pennsylvania 19104-4283 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field